Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) P/B ratio
As of 5 November 2026, Teleflex Incorporated (TFX) trades at a P/B ratio of 2.3×. Over the past ten years it has ranged from 1.1× (July 2025) to 6.4× (August 2019); the current reading is higher than 21% of that period. That is in line with the Medical Instruments & Supplies industry median of 2.3× and in line with the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.7× | (10.56%) |
| FY2024 | 1.9× | (26.46%) |
| FY2023 | 2.6× | (9.06%) |
| FY2022 | 2.9× | (28.80%) |
| FY2021 | 4.1× | (28.64%) |
| FY2020 | 5.7× | (1.76%) |
| FY2019 | 5.8× | 25.55% |
| FY2018 | 4.6× | (1.42%) |
| FY2017 | 4.7× | 46.48% |
| FY2016 | 3.2× | 18.54% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 1.9× | 10.77% |
| Mar 2026 | 1.7× | (1.52%) |
| Dec 2025 | 1.7× | 23.05% |
| Sep 2025 | 1.4× | 14.69% |
| 42 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| NVST Envista Holdings Corporation compare | 1.3× |
| MMED MiniMed Group, Inc. compare | 1.4× |
| AVTR Avantor, Inc. compare | 1.8× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| TFX Teleflex Incorporated | 2.3× |
| MMSI Merit Medical Systems, Inc. compare | 3.1× |
| ATR AptarGroup, Inc. compare | 3.5× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement